These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 10874018)

  • 21. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
    Shibata MA; Shirai T; Ogawa K; Takahashi S; Wild CP; Montesano R; Tsuda H; Ito N
    Carcinogenesis; 1994 Dec; 15(12):2965-8. PubMed ID: 8001265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible application of human c-Ha-ras proto-oncogene transgenic rats in a medium-term bioassay model for carcinogens.
    Ohnishi T; Fukamachi K; Ohshima Y; Jiegou X; Ueda S; Iigo M; Takasuka N; Naito A; Fujita K; Matsuoka Y; Izumi K; Tsuda H
    Toxicol Pathol; 2007 Apr; 35(3):436-43. PubMed ID: 17474063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of catechol on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    La Voie EJ; Shigematsu A; Mu B; Rivenson A; Hoffmann D
    Jpn J Cancer Res; 1985 Apr; 76(4):266-71. PubMed ID: 3924700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of urinary bladder carcinogenicity of sodium L-ascorbate in human c-Ha-ras proto-oncogene transgenic rats.
    Morimura K; Kang JS; Wei M; Wanibuchi H; Tsuda H; Fukushima S
    Toxicol Pathol; 2005; 33(7):764-7. PubMed ID: 16316941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Enomoto T; Ward JM; Perantoni AO
    Carcinogenesis; 1990 Dec; 11(12):2233-8. PubMed ID: 2265474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squamous and transitional elements in rat bladder carcinomas induced by N-butyl-N-4-hydroxybutyl-nitrosamine (BBN). A study of cytokeratin expression.
    Herman CJ; Vegt PD; Debruyne FM; Vooijs GP; Ramaekers FC
    Am J Pathol; 1985 Sep; 120(3):419-26. PubMed ID: 2412446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Fujita J; Ohuchi N; Ito N; Reynolds SH; Yoshida O; Nakayama H; Kitamura Y
    J Natl Cancer Inst; 1988 Mar; 80(1):37-43. PubMed ID: 3276902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.
    Iida K; Itoh K; Maher JM; Kumagai Y; Oyasu R; Mori Y; Shimazui T; Akaza H; Yamamoto M
    Carcinogenesis; 2007 Nov; 28(11):2398-403. PubMed ID: 17602169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soft agar colony formation of bladder cells during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine and application to detection of bladder cancer promoters.
    Hashimura T; Kanamaru H; Yoshida O
    Jpn J Cancer Res; 1987 May; 78(5):473-9. PubMed ID: 3112059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
    Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Masui T; Dong Y; Yamamoto S; Takada N; Nakanishi H; Inada K; Fukushima S; Tatematsu M
    Cancer Lett; 1996 Jul; 105(1):105-12. PubMed ID: 8689624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of involvement of p53 gene mutations in N-methyl-N-nitrosourea-induced bladder tumor progression in N-butyl-N-(4-hydroxybutyl)nitrosamine-treated rats and no suppression by indomethacin.
    Ozaki M; Shibata MA; Takahashi S; Orita SI; Kawabe M; Shirai T
    Cancer Lett; 1997 May; 115(2):249-55. PubMed ID: 9149132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in dogs.
    Okajima E; Hiramatsu T; Hirao K; Ijuin M; Hirao Y; Babaya K; Ikuma S; Ohara S; Shiomi T; Hijioka T; Ohishi H
    Cancer Res; 1981 May; 41(5):1958-66. PubMed ID: 7214364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.
    Baffa R; Fassan M; Sevignani C; Vecchione A; Ishii H; Giarnieri E; Iozzo RV; Gomella LG; Croce CM
    Carcinogenesis; 2008 Apr; 29(4):846-8. PubMed ID: 18192690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
    Irving CC; Murphy WM; Daniel DS
    J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression in the bladder carcinoma rat model.
    Ariel I; Ayesh S; Gofrit O; Ayesh B; Abdul-Ghani R; Pizov G; Smith Y; Sidi AA; Birman T; Schneider T; de Groot N; Hochberg A
    Mol Carcinog; 2004 Oct; 41(2):69-76. PubMed ID: 15378645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemically induced tumors in transgenic mice carrying prototype human c-Ha-ras genes.
    Katsuki M; Ando K; Saitoh A; Doi S; Kimura M; Takahashi R; Hasegawa T; Yokoyama M; Nomura T; Izawa M
    Princess Takamatsu Symp; 1991; 22():249-57. PubMed ID: 1844246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
    Dunois-Lardé C; Levrel O; Brams A; Thiery JP; Radvanyi F
    Mol Carcinog; 2005 Mar; 42(3):142-9. PubMed ID: 15690367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Miyata Y; Fukushima S; Hirose M; Masui T; Ito N
    Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.